Updated Mar 17, 2026 by PlayWay
PlayWay S.A. initiated an accelerated bookbuilding process on January 23, 2023, to sell up to 860,152 shares of Movie Games S.A., representing 33.43% of the company's total share capital.
The divestment is part of a strategic portfolio realignment, with PlayWay intending to reallocate capital from the sale toward new and existing projects across its broader group.
Ipopema Securities S.A. was appointed to manage the sale, which was structured as a prospectus-exempt offering targeting institutional and qualified investors.
The bookbuilding process was scheduled to conclude by January 26, 2023, with the final share price and total volume determined by market demand and management discretion.
PlayWay may enter into a lock-up agreement for its remaining shares in Movie Games S.A. depending on the final volume of the divestment.
The offering was restricted to specific jurisdictions and excluded investors in the United States, Australia, Canada, Japan, and South Africa due to local securities regulations.
PlayWay S.A. initiated an accelerated bookbuilding process on January 23, 2023, to sell up to 860,152 shares of Movie Games S.A., representing 33.43% of the company's total share capital.
The divestment is part of a strategic portfolio realignment, with PlayWay intending to reallocate capital from the sale toward new and existing projects across its broader group.
Ipopema Securities S.A. was appointed to manage the sale, which was structured as a prospectus-exempt offering targeting institutional and qualified investors.
The bookbuilding process was scheduled to conclude by January 26, 2023, with the final share price and total volume determined by market demand and management discretion.
PlayWay may enter into a lock-up agreement for its remaining shares in Movie Games S.A. depending on the final volume of the divestment.
The offering was restricted to specific jurisdictions and excluded investors in the United States, Australia, Canada, Japan, and South Africa due to local securities regulations.